Polyglandular hyperfunction

E4_POLYHYPER

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E31.1
Cause of death: ICD-10 E31.1

2 out of 7 registries used, show all original rules.

10

diagram downward connector

Check minimum number of events None

10

diagram downward connector

Include endpoints None

10

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

10

diagram downward connector
E4_POLYHYPER

Control definitions

Control exclude E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E31
Name in latin Hyperfunctio polyglandularis

Summary Statistics

Key figures

All Female Male
Number of individuals 10 9 -
Unadjusted prevalence (%) 0.00 0.00 -
Mean age at first event (years) 41.44 41.30 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_POLYHYPER – Polyglandular hyperfunction
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Polyglandular hyperfunction

Endpoint not on priority list, no data to show.